Drugs / Danlou Tablets
Danlou Tablets
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT02675322 | Jan 2012 → Jan 2015 | acute myocardial infarction | shuai Mao | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02526381 | Jul 2015 → Dec 2017 | coronary artery disorder | Tianjin University of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Danlou Tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02675322 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Danlou tablets, a patented Chinese Medicine” PMID 27825334 ↗ Nov 2016 |
| Route | Oral | “taken orally” NCT02526381 ↗ |